Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapyNAKAHIRA, Atsushi; OGINO, Hitoshi; SASAKI, Hiroaki et al.European journal of cardio-thoracic surgery. 2007, Vol 32, Num 2, pp 388-390, issn 1010-7940, 3 p.Article

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105YAMAMOTO, Nobuyuki; NAKAGAWA, Kazuhiko; SAWA, Toshiyuki et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3739-3745, issn 0732-183X, 7 p.Article

Phase II Trial of Preoperative Chemoradiotherapy Followed by Surgical Resection in Patients With Superior Sulcus Non-Small-Cell Lung Cancers : Report of Japan Clinical Oncology Group Trial 9806KUNITOH, Hideo; KATO, Harubumi; NAKAGAWA, Ken et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 644-649, issn 0732-183X, 6 p.Article

Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancerFUJITA, Shiro; KATAKAMI, Nobuyuki; TAKAHASHI, Yutaka et al.European journal of cardio-thoracic surgery. 2006, Vol 29, Num 6, pp 896-901, issn 1010-7940, 6 p.Article

A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)GOTO, Koichi; NISHIO, Makoto; FUKUYAMA, Tamaki et al.Lung cancer. 2013, Vol 82, Num 1, pp 109-114, issn 0169-5002, 6 p.Article

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selectionHATA, Akito; KATAKAMI, Nobuyuki; NISHIYAMA, Akihiro et al.Lung cancer. 2011, Vol 74, Num 2, pp 268-273, issn 0169-5002, 6 p.Article

Epidermal growth factor receptor gene mutations in papillary thyroid carcinomaMASAGO, Katsuhiro; ASATO, Ryo; FUJITA, Shiro et al.International journal of cancer (Print). 2009, Vol 124, Num 11, pp 2744-2749, issn 0020-7136, 6 p.Article

A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)HATTORI, Yoshihiro; SATOUCHI, Miyako; MORITA, Satoshi et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 17-23, issn 0344-5704, 7 p.Article

Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemiaKINOSHITA, Makoto; FUJITA, Yasuyuki; KURIMOTO, Yasuo et al.Atherosclerosis. 2012, Vol 224, Num 2, pp 440-445, issn 0021-9150, 6 p.Article

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer : Results of the west japan thoracic oncology group trial (WJTOG 9904)KUDOH, Shinzoh; TAKEDA, Koji; SETO, Takashi et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3657-3663, issn 0732-183X, 7 p.Article

Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese Taxotere Lung Cancer Study GroupKUBOTA, Kaoru; WATANABE, Koshiro; YONEDA, Shuichi et al.Journal of clinical oncology. 2004, Vol 22, Num 2, pp 254-261, issn 0732-183X, 8 p.Article

Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancerKANEDA, Toshihiko; HATA, Akito; TOMIOKA, Hiromi et al.Lung cancer. 2014, Vol 86, Num 2, pp 213-218, issn 0169-5002, 6 p.Article

LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non―Small―Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or BothKATAKAMI, Nobuyuki; ATAGI, Shinji; NISHIO, Kazuto et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3335-3341, issn 0732-183X, 7 p.Article

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non―Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)TAKEDA, Koji; HIDA, Toyoaki; SASAKI, Jiichiro et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 753-760, issn 0732-183X, 8 p.Article

Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908KATAKAMI, Nobuyuki; SUGIURA, Takahiko; NOGAMI, Toshiji et al.Lung cancer. 2004, Vol 43, Num 1, pp 93-100, issn 0169-5002, 8 p.Article

Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized studyHASEGAWA, Tsuyoshi; ISHIHARA, Kyosuke; TAKAKURA, Shunji et al.Internal medicine (Tokyo. 1992). 2000, Vol 39, Num 10, pp 794-797, issn 0918-2918Article

The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung diseaseSHIMIZU, Ryoko; FUJIMOTO, Daichi; OTSUKA, Kojiro et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 6, pp 1159-1166, issn 0344-5704, 8 p.Article

Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinomaFUJIMOTO, Daichi; TOMII, Keisuke; OTSUKA, Kyoko et al.Lung cancer. 2013, Vol 80, Num 2, pp 159-164, issn 0169-5002, 6 p.Article

Rebiopsy of Non―Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: Comparison Between T790M Mutation-Positive and Mutation-Negative PopulationsHATA, Akito; KATAKAMI, Nobuyuki; MATSUMOTO, Takeshi et al.Cancer. 2013, Vol 119, Num 24, pp 4325-4332, issn 0008-543X, 8 p.Article

A Phase 3 Study of Induction Treatment With Concurrent Chemoradiotherapy Versus Chemotherapy Before Surgery in Patients With Pathologically Confirmed N2 Stage IIIA Nonsmall Cell Lung Cancer (WJTOG9903)KATAKAMI, Nobuyuki; TADA, Hirohito; MITSUDOMI, Tetsuya et al.Cancer. 2012, Vol 118, Num 24, pp 6126-6135, issn 0008-543X, 10 p.Article

Amrubicin at a lower-dose with routine prophylactic use of granulocyte-colony stimulating factor for relapsed small-cell lung cancerHATA, Akito; KATAKAMI, Nobuyuki; NISHIMURA, Takashi et al.Lung cancer. 2011, Vol 72, Num 2, pp 224-228, issn 0169-5002, 5 p.Article

Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non-Small Cell Lung Cancer : West Japan Thoracic Oncology Group 3505OKAMOTO, Isamu; NISHIMURA, Takashi; NAKAGAWA, Kazuhiko et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5250-5254, issn 1078-0432, 5 p.Article